Christine S. Rollier

Author

Also Known As

C Rollier, C S Rollier, C. Rollier, C.S. Rollier, Christine Rollier, Christine S Rollier, Christine S. Rollier, Graham Freimanis, Laura Silva-Reyes, Rollier, C

100

Publications

13.3K

Citations

H-Index

Concepts

All Affiliations

University of Oxford Jenner Institute Oxford BioMedica (United Kingdom)Biomedical Primate Research Centre Inserm

About

Christine S. Rollier is an author at University of Oxford specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	3.7K
2	Allergy	2	2	58
3	Health Sciences	1	1	32
4	Public Health	1	1	35
5	Cell Biology	1	1	21

Christine S. Rollier

Publications

11.9K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2020	5K
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley, The Lancet VaccinationVaccine SafetyPhase 1/2Vaccine DevelopmentPreliminary Report	2020	2.6K
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2021	1.2K
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison Mark Ainsworth, Monique Andersson, Kathryn Auckland, The Lancet Infectious Diseases	2020	397
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses Jordan R. Barrett, Sandra Belij‐Rammerstorfer, Christina Dold, Nature Medicine VaccinationPhase 1/2Vaccine DevelopmentImmunologyHumoral Immunity	2020	334
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity David Ahern, Zhichao Ai, Mark Ainsworth, Cell	2022	319
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) Amy Flaxman, Natalie G. Marchevsky, Daniel Jenkin, The Lancet	2021	253
Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass Robert Alcock, Matthew G. Cottingham, Christine S. Rollier, Science Translational Medicine	2010	163
MAIT cell activation augments adenovirus vector vaccine immunogenicity Nicholas M. Provine, Ali Amini, Lucy C. Garner, Science	2021	129
Upregulation of Indoleamine 2,3-Dioxygenase in Hepatitis C Virus Infection Esther Larrea, José Ignacio Riezu‐Boj, Lucía Gil‐Guerrero, Journal of Virology	2007	123

Page 1